• 1. Depart-ment of Cardiothoracic Surgery, Wuhu Second People's Hospital, Wuhu 241000, Anhui, P. R. China;
  • 2. Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
YANGJian, Email: ak8328@hotmail.com
Export PDF Favorites Scan Get Citation

Objective To evaluate clinical outcomes of thoracic endovascular aortic repair (TEVAR)for the treatment of Stanford type B aortic dissection (AD)and descending aortic aneurysm. Methods Clinical data of 20 patients with Stanford type B AD or descending aortic aneurysm who underwent TEVAR in West China Hospital from March to June 2013 were retrospectively analyzed. There were 19 male and 1 female patients with their age of 41-76 (58.3±10.2)years. Clinical outcomes were analyzed. Results Among the 20 patients, 18 patients were successfully discharged, 1 patient refused further postoperative treatment and was discharged, and 1 patient died postoperatively. Sixteen patients (88.9%)were followed up for over 3 months. In all the patients during follow-up, true lumen diameter recovered within the scope of intravascular stents, and there was thrombosis in false lumen or aneurysm lumen. Conclusion TEVAR provides a new choice with significant advantages for the treatment of Stanford type B AD, especially for the elderly and patients with concomitant serious diseases, so it is worthy of clinical application.

Citation: LIChang-qing, YANGJian. Thoracic Endovascular Aortic Repair for Stanford Type B Aortic Dissection. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2014, 21(3): 364-366. doi: 10.7507/1007-4848.20140100 Copy

  • Previous Article

    Clinical Analysis of Thyroid Carcinoma in 5 Cases
  • Next Article

    Clinical Analysis of Thyroid Carcinoma in 5 Cases